Schranz, Asher J.
Barrett, Jessica
Hurt, Christopher B.
Malvestutto, Carlos
Miller, William C.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32AI070114)
National Institute of Mental Health (K23MH099941)
National Institute on Drug Abuse (UG3DA044823)
Article History
First Online: 23 May 2018
Compliance with Ethical Standards
:
: Asher J. Schranz is supported by the National Institute of Allergy and Infectious Diseases (T32AI070114).Christopher B. Hurt is supported by the National Institute for Mental Health (K23MH099941) and the National Institute for Drug Abuse (UG3DA044823), and has received salary support for supervising a clinical trial of HCV treatment, under an institutional contract between UNC and AbbVie. William C Miller and Carlos Malvestutto were supported by the National Institute for Drug Abuse (UG3DA044822).
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.